News and Announcements
Atomo Diagnostics Wins State Funding to Make HIV Self Test
- Published November 30, 2015 11:37AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
November 28, 2015, PR.com
Atomo Diagnostics is delighted to announce that the company has been awarded a grant of A$1.8 million (US$1.3M) from the New South Wales Medical Device Fund 2015-2016 for the development of a self-test for rapid detection of HIV. The Atomo HIV Self Test will be easier to use than any HIV self-test available globally, and will provide users with clear and accurate test results within minutes.
Atomo Diagnostics is a Sydney-headquartered healthcare company that designs, develops and commercialises rapid diagnostic tests that offer best-in-class safety and ease-of-use. Atomo is Australia’s only manufacturer of rapid diagnostic tests for detection of HIV, and currently sells most of its tests to professional users in Africa.
The NSW Medical Device Fund is an annual merit-based commercialisation programme run by the NSW Government Department of Health. The Fund helps to promote and support the development of new and innovative medical devices in NSW, with particular focus on technologies that have the potential to provide significant global health benefits.
To read the full story, please click here.